Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cytek Biosciences Inc (NQ: CTKB )

13.15 -0.04 (-0.30%)
Streaming Delayed Price Updated: 10:27 AM EST, Feb 7, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 40,223
Open 13.14
Bid (Size) 13.13 (3)
Ask (Size) 13.16 (4)
Prev. Close 13.19
Today's Range 12.94 - 13.22
52wk Range 7.380 - 16.05
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Cytek® Biosciences Partners with Bio-Rad to Expand Reagent Portfolios
New Agreement Enhances High-Parameter Panels on Cytek Cell Analysis Systems 
From Cytek Biosciences, Inc.
Via Globe NewsWire
Cytek Biosciences to Participate in Upcoming Investor Conferences
From Cytek Biosciences, Inc.
Via Globe NewsWire

Performance

YTD
+29.94%
+29.94%
1 Month
+24.41%
+24.41%
3 Month
-10.54%
-10.54%
6 Month
-12.51%
-12.51%
1 Year
-9.81%
-9.81%

More News

Read More
Oak Street Health, PriceSmart And Some Other Big Stocks Moving Higher In Tuesday's Pre-Market Session
Via Benzinga
Cytek Biosciences Earnings Perspective: Return On Capital Employed
Via Benzinga
Recap: Cytek Biosciences Q2 Earnings
Via Benzinga
Earnings Preview: Cytek Biosciences
Via Benzinga
5 Most Cheapest Stocks In The Healthcare Sector: Bio-Techne, Mirati Therapeutics And More
Via Benzinga
Cytek Biosciences to Participate in the Piper Sandler Healthcare Conference
From Cytek Biosciences, Inc.
Via Globe NewsWire
Cytek® Biosciences Introduces Cytek Cloud
From Cytek Biosciences, Inc.
Via Globe NewsWire
Where Cytek Biosciences Stands With Analysts
Via Benzinga
Earnings Scheduled For May 11, 2022
Via Benzinga
Cytek Biosciences Reports Third Quarter 2022 Financial Results
From Cytek Biosciences, Inc.
Via Globe NewsWire
Earnings Outlook For Cytek Biosciences
Via Benzinga
Cytek® Biosciences Names Chris Williams Chief Operating Officer
From Cytek Biosciences, Inc.
Via Globe NewsWire
Cytek Biosciences to Report Third Quarter 2022 Financial Results on November 9, 2022
From Cytek Biosciences, Inc.
Via Globe NewsWire
Cytek to Participate in the 31st Annual Credit Suisse Healthcare Conference
From Cytek Biosciences, Inc.
Via Globe NewsWire
Pinterest, Perion Network And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
Via Benzinga
Piper Sandler Maintains Overweight Rating for Cytek Biosciences: Here's What You Need To Know
Via Benzinga
Analyst Ratings for Cytek Biosciences
Via Benzinga
Analyst Ratings for Cytek Biosciences
Via Benzinga
74 Biggest Movers From Yesterday
Via Benzinga
Goldman Sachs Maintains Buy Rating for Cytek Biosciences: Here's What You Need To Know
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.